Company information lookup

BIOTRON LIMITED (BIT)

Conduct clinical trials, research and commercialisation of a number of anti-viral (HCV and HIV) drugs developed from biomedical projects researched at the John Curtin School of Medical Research.

On this page you will find:

Company snapshot
Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products
ASX CFDs

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
BIT 0.096 0% 0.096 0.100 0.096 0.096 0.096 12,500

ASX Find a broker tool

Helps you find an ASX broker based on your needs and where you live.

BIOTRON LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code BIT
Securities
Official Listing Date 24 January, 2001
GICS Industry Group Pharmaceuticals, Biotechnology & Life Sciences
Exempt Foreign? No
Internet Address http://www.biotron.com.au
Registered Office Address Level 2, 66 Hunter Street, SYDNEY, NSW, AUSTRALIA, 2000
Head Office Telephone (02) 9300 3344
Head Office Fax (02) 9221 6333
Share Registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED
117 VICTORIA STREET, WEST END, QLD, AUSTRALIA, 4101
Share Registry Telephone 1300 787 272
Directors / Senior Management
Mr Michael Hoy (Non Exec. Chairman, Independent Director)
Dr Michelle Miller (Managing Director)
Mr Bruce Hundertmark (Non Exec. Director, Independent Director)
Dr Susan Pond (Non Exec. Director, Independent Director)
Mr Robert Thomas (Non Exec. Director, Independent Director)
Mr Denis Newell Wade (Non Exec. Director, Independent Director)
Company Secretary Mr Peter Nightingale
Principal Activities Conduct clinical trials, research and commercialisation of a number of anti-viral (HCV and HIV) drugs developed from biomedical projects researched at the John Curtin School of Medical Research.

BIOTRON LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
01/05/2013   Presentation at European Liver Conference 2 PDF
30/04/2013 asterix Appendix 4C - quarterly 5 PDF
26/04/2013   CEO Presentation at the 2013 BIO International Convention 12 PDF
10/04/2013   Letter to Shareholders 3 PDF
19/03/2013 asterix HIV TRIAL VALIDATES NOVEL DRUG MECHANISM 2 PDF
27/02/2013 asterix Half Yearly Report and Accounts 19 PDF
17/01/2013 asterix Appendix 4C - quarterly 5 PDF
14/12/2012 asterix Biotron Completes Clinical Stage of HIV Clinical Trial 2 PDF
28/11/2012   Results of Meeting 2 PDF
28/11/2012   Chairman's Address and Presentation to the AGM 1 PDF

> search for past company announcements

Viewing Company Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
24 May 2013 0.096 0% 0.096 0.096 12,500
21 May 2013 0.096 0% 0.096 0.096 38,000
17 May 2013 0.096 0% 0.096 0.096 10,000
16 May 2013 0.096 -4% 0.097 0.096 79,400
15 May 2013 0.100 0% 0.100 0.096 20,286

* Volume of shares shown represents only those shares traded on ASX.

BIOTRON LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security BIT. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security BIT

Warrants & Structured Products

No warrants & Structured Products are available over the security BIT

ASX CFDs

No Contracts For Differences are available over the security BIT